Stratum Corneum Toll-like Receptor 3 Expressions Correlate with the Severity of Atopic Dermatitis Lesions
Overview
Authors
Affiliations
Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications.
Vafaeian A, Rajabi F, Rezaei N Heliyon. 2025; 11(3):e42226.
PMID: 40007792 PMC: 11850170. DOI: 10.1016/j.heliyon.2025.e42226.
Toll-like receptor 3: a double-edged sword.
Hsieh M, Nishizaki D, Adashek J, Kato S, Kurzrock R Biomark Res. 2025; 13(1):32.
PMID: 39988665 PMC: 11849352. DOI: 10.1186/s40364-025-00739-5.
Toll-like receptors: their roles in pathomechanisms of atopic dermatitis.
Tamagawa-Mineoka R Front Immunol. 2023; 14:1239244.
PMID: 37731494 PMC: 10508237. DOI: 10.3389/fimmu.2023.1239244.
Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis.
Koumaki D, Gregoriou S, Evangelou G, Krasagakis K J Clin Med. 2023; 12(6).
PMID: 36983094 PMC: 10054239. DOI: 10.3390/jcm12062091.
Anti-pruritic effect of isothiocyanates: Potential involvement of toll-like receptor 3 signaling.
Moriyama M, Konno M, Serizawa K, Yuzawa N, Majima Y, Hayashi I Pharmacol Res Perspect. 2022; 10(6):e01038.
PMID: 36507603 PMC: 9741980. DOI: 10.1002/prp2.1038.